Researchers identify new therapeutic pathways for Alzheimer's disease

Recent scientific studies have identified potential new methods to address sleep loss and metabolic waste in Alzheimer's disease models.

Researchers at the University of Kentucky, led by Dr. Shannon L. Macauley, discovered that microglia—the brain's immune cells—may be the primary factor in sleep loss associated with Alzheimer's. By using a drug to temporarily eliminate these cells in mouse models, the team was able to recover more than two hours of sleep per night. This suggests that the brain's immune response, rather than just amyloid plaques, may be driving sleep disruption.

Separately, a study published in Science Advances involving researchers from China explores a non-invasive technique using ultra-short frequency electromagnetic waves. This method aims to enhance the glymphatic system, the brain's natural waste clearance network. In mouse models, ten minutes of stimulation increased fluid movement to clear harmful substances and boosted delta waves associated with deep sleep. The technique also showed improvements in cognitive abilities and a reduction in brain edema in models of traumatic brain injury.